Medications

Nasal spray to fight COVID-19 heads to clinical trial

An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the University of Melbourne and Monash University receive $4.2 million to establish a six-month clinical trial ...

Medications

Heparin targets coronavirus spike protein, research shows

An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by ...

Diseases, Conditions, Syndromes

Researchers working on nasal spray to block COVID-19

A team of researchers, including faculty from the University of Mississippi schools of Pharmacy and Medicine, are developing a treatment that could be effective at preventing COVID-19. The good news is that it's something ...

page 2 from 11